TGV Sraac Ltd
₹ 98.2
0.01%
06 Jun
2:14 p.m.
About
Incorporated in 1981, TGV SRAAC Ltd is a flagship company of the TGV Group. It manufactures Chlor-Alkali products, Castor Derivatives and Fatty Acids[1]
Key Points
- Market Cap ₹ 1,052 Cr.
- Current Price ₹ 98.2
- High / Low ₹ 182 / 62.8
- Stock P/E 2.90
- Book Value ₹ 97.7
- Dividend Yield 0.00 %
- ROCE 37.8 %
- ROE 40.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 1.00 times its book value
- Company is expected to give good quarter
- Company has delivered good profit growth of 65.0% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chlor Alkali / Soda Ash
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
782 | 817 | 769 | 777 | 816 | 908 | 1,046 | 1,205 | 1,040 | 1,009 | 1,525 | 2,326 | |
681 | 695 | 670 | 669 | 710 | 776 | 866 | 974 | 884 | 860 | 1,204 | 1,789 | |
Operating Profit | 101 | 121 | 99 | 108 | 107 | 132 | 180 | 231 | 157 | 149 | 322 | 537 |
OPM % | 13% | 15% | 13% | 14% | 13% | 15% | 17% | 19% | 15% | 15% | 21% | 23% |
5 | 4 | -19 | 0 | 5 | 9 | 7 | -6 | 8 | 10 | 7 | 6 | |
Interest | 42 | 45 | 40 | 40 | 44 | 60 | 58 | 71 | 44 | 48 | 51 | 28 |
Depreciation | 37 | 41 | 36 | 36 | 35 | 47 | 77 | 58 | 56 | 63 | 69 | 74 |
Profit before tax | 28 | 40 | 4 | 32 | 33 | 34 | 53 | 95 | 64 | 48 | 209 | 442 |
Tax % | 50% | 6% | -11% | 30% | 26% | 52% | 44% | 28% | 26% | 40% | 36% | 18% |
Net Profit | 14 | 38 | 5 | 22 | 24 | 17 | 30 | 68 | 47 | 29 | 134 | 362 |
EPS in Rs | 5.31 | 0.64 | 2.81 | 2.95 | 1.90 | 3.22 | 7.08 | 4.65 | 2.70 | 12.53 | 33.77 | |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 17% |
3 Years: | 31% |
TTM: | 52% |
Compounded Profit Growth | |
---|---|
10 Years: | 25% |
5 Years: | 65% |
3 Years: | 97% |
TTM: | 171% |
Stock Price CAGR | |
---|---|
10 Years: | 30% |
5 Years: | 22% |
3 Years: | 73% |
1 Year: | 19% |
Return on Equity | |
---|---|
10 Years: | 16% |
5 Years: | 21% |
3 Years: | 24% |
Last Year: | 40% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
86 | 90 | 94 | 98 | 102 | 106 | 92 | 97 | 102 | 107 | 107 | 107 | |
Reserves | 135 | 172 | 177 | 199 | 227 | 258 | 290 | 373 | 430 | 503 | 636 | 939 |
385 | 322 | 313 | 327 | 432 | 457 | 439 | 328 | 420 | 499 | 461 | 232 | |
207 | 212 | 231 | 213 | 230 | 276 | 269 | 298 | 323 | 344 | 393 | 404 | |
Total Liabilities | 794 | 777 | 796 | 818 | 972 | 1,078 | 1,091 | 1,095 | 1,275 | 1,453 | 1,598 | 1,683 |
460 | 456 | 431 | 444 | 660 | 698 | 669 | 636 | 808 | 774 | 902 | 1,042 | |
CWIP | 53 | 70 | 126 | 124 | 0 | 0 | 13 | 77 | 29 | 125 | 55 | 11 |
Investments | 2 | 2 | 2 | 2 | 2 | 9 | 14 | 10 | 8 | 89 | 89 | 31 |
279 | 250 | 237 | 248 | 309 | 371 | 394 | 373 | 430 | 465 | 551 | 600 | |
Total Assets | 794 | 777 | 796 | 818 | 972 | 1,078 | 1,091 | 1,095 | 1,275 | 1,453 | 1,598 | 1,683 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
105 | 27 | 78 | 65 | 50 | 142 | 153 | 202 | 122 | 132 | 213 | 429 | |
-67 | -53 | -75 | -52 | -132 | -109 | -75 | -55 | -188 | -163 | -147 | -169 | |
-2 | -3 | -12 | -2 | 91 | -33 | -76 | -145 | 65 | 58 | -83 | -255 | |
Net Cash Flow | 36 | -29 | -9 | 11 | 9 | -0 | 2 | 2 | -0 | 26 | -18 | 5 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 31 | 27 | 25 | 25 | 29 | 30 | 37 | 30 | 29 | 36 | 56 | 36 |
Inventory Days | 71 | 60 | 77 | 50 | 82 | 79 | 89 | 125 | 167 | 126 | 101 | 83 |
Days Payable | 66 | 74 | 93 | 65 | 77 | 98 | 80 | 67 | 73 | 81 | 66 | 39 |
Cash Conversion Cycle | 36 | 13 | 8 | 10 | 34 | 11 | 45 | 89 | 123 | 81 | 90 | 80 |
Working Capital Days | 16 | 3 | -9 | -1 | 21 | 7 | 11 | 35 | 46 | 37 | 54 | 40 |
ROCE % | 12% | 14% | 12% | 13% | 11% | 12% | 13% | 22% | 12% | 9% | 22% | 38% |
Documents
Announcements
- Communication To Shareholders Holding In Physical Form To Furnish KYC Details And Nomination For Updation Of Data In Company Records As Per SEBI Circular Dt.16.03.2023-SCRIP Code : 507753 1 Jun
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 May - Submission of Audited Financial Results for the 4th quarter and year ended 31.03.2023 published in News Papers.
- Audited Financial Results For The 4Th Quarter And Year Ended 31.03.2023. 29 May
- Board Meeting Outcome for Audited Financial Results For The 4Th Quarter And Year Ended 31St March, 2023. 29 May
- Announcement under Regulation 30 (LODR)-Dividend Updates 29 May
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:[1]
Company's operations are divided into 3 segments viz. Chemicals Division, Oils and Fats Division and Power Division.
a) Castor Derivatives:[2] Hydrogenated Castor Oil, 12-Hydroxy Stearic Acid, Ricinoleic Acid, Refined Castor Oil, Methyl, etc.
b) Chlor-Alkali Products:[3] Caustic Soda, Liquid Chlorine, Hydrochloric Acid, Caustic Potash, Sodium Hypochlorite (Liquid), Barium Sulphate (Precipitated powder), Hydrogen Gas, Potassium Carbonate
c) Fatty Acids:[4] Stearic Acid, Soap Noodles, Glycerine (Refined
/ Chemically Pure), Hydrogenated Palm Stearin
d) Chloromethanes:[5] Methyl Chloride, Methylene Chloride, Chloroform, Carbon Tetra Chloride
e) Toilet Soap:[6] Royal Saffron Sandal, Cool Lime, Royal HE-MAN, Baby Doctor, Royal Rose
f) Power Projects:[7][8]
Company has established power generation for captive use and for commercial purposes. There are no commercial operations at Bellary Power Plant due to expiry of Power Purchase Agreement (PPA) by KPTCL. Company is looking out for other viable options including its sale or relocation of the Plant